Ocular complications associated with diabetes mellitus are progressive and becoming one of the most important causes of morbidity worldwide. The purpose of the study is to evaluate the protective effect of Polygonatum sibiricum polysaccharide, an important component of Polygonatum sibiricum, on ocular complications in streptozotocin-induced diabetes mellitus rats. Sprague Dawley rats were made diabetic with streptozotocin(60 mg/kg, i.v.) and then the rats were treated with Polygonatum sibiricum polysaccharide 200, 400 and 800 mg/kg.d by gavage for 12 weeks. Biochemical analysis indicated that Polygonatum sibiricum polysaccharide lowered the levels of fasting blood glucose and glycated hemoglobin in blood and elevated the levels of insulin and C-peptide in plasma of diabetes mellitus rats in a dose-dependent manner. Physical measurements revealed that Polygonatum sibiricum polysaccharide improved clinical symptoms of polydipsia, polyphagia, polyuria and weight loss in diabetes mellitus rats. The content of malondialdehyde and activity of superoxide dismutase in plasma were determined, and the data showed Polygonatum sibiricum polysaccharide suppressed oxidative stress reaction. Lens opacification was observed using slit lamp illumination, and the data showed Polygonatum sibiricum polysaccharide delayed cataract progression in a dose-dependent manner. Electroretinogram showed Polygonatum sibiricum polysaccharide treatment reversed the decrease of electroretinogram b and OPs2 waves' amplitudes. Flash-visual evoked potential test indicated that the peak time of P2 wave was prolonged, and the amplitude of N2-P2 was lowered in diabetes mellitus group, and Polygonatum sibiricum polysaccharide suppressed these changes. Fundus fluorescein angiography showed Polygonatum sibiricum polysaccharide alleviated the retinal vasculopathy in a dose-dependent manner. In conclusion, these results suggest that the administration of Polygonatum sibiricum polysaccharide slows the progression of diabetic retinopathy and cataract through alleviating hyperglycemia and reducing oxidative stress in streptozotocin-induced diabetes mellitus rats.
Introduction
With the rising of human being's life standard, diabetes mellitus (DM) has become the most prevalent endocrine disorder around the world. A report published by the International Diabetes Federation currently indicates that DM has impact on at least 378 million people worldwide, and this figure is most likely to be doubled by 2035. 1 DM alone is not horrible, but its complications are more than horrible. DM can lead to several ocular complications such as diabetic retinopathy (DR), cataract, glaucoma, etc., which remains a major cause of blindness. 2 DR, one of the most common microvascular complications in DM, is the leading cause of blindness among working people in developed countries. 3 For patients whose diabetic duration is less than five years, DR morbidity is approximately 38-39%, and for those whose duration is 5-10 years, the morbidity is approximately 50-56.7%, whereas for patients whose diabetic duration is more than 10 years, the morbidity is approximately 69-90%. 4 Good blood glucose control and attenuating other risk factors such as oxidative stress are main goals to prevent ocular complications of DM.
In spite of presently available conventional drugs (insulin (INS), sulfonylureas, biguanides, a-glucosidase inhibitors, thiazolidinediones and dipeptidyl peptidase-4inhibitors), the treatment of DM has been a difficult task. This is due to the unwanted side-effects associated with the use of conventional drugs, including hypoglycemia, weight gain, hypersensitivity, gastrointestinal discomfort, nausea, liver and heart failure, and diarrhoea. 5 However, traditional Chinese medicine can curve these problems, since fewer side-effects have been reported with the use of plants in the treatment of several diseases. 6, 7 Polygonatum sibiricum grows in the wild and is cultivated as a traditional medicinal herb and foodstuff in China. As a common Chinese medicine, P. sibiricum is considered to have the functions of compensating vital essence, removing dryness, promoting secretion of fluid and quenching thirst. 8 Previous study also indicated P. sibiricum improved obesity conditions and INS resistance. 9 In recent years, many components have been isolated from P. sibiricum and Polygonatum sibiricum polysaccharide (PSP) is the major medicinal effective ingredient. As an important component of P. sibiricum, PSP is known to have low toxicity and is considered to be suitable for long-term administration. In this study, we investigated the effect of PSP treatment on ocular lesion of streptozotocin (STZ)-induced diabetic rats so as to elucidate the therapeutical effect of PSP on DM and its ocular complications.
Materials and methods

Materials and reagents
PSP was purchased from Taian Zhonghui Plant Biochemical Co. Ltd (China), and the essence of PSP is 98% in purity. STZ was purchased from Sigma (USA). Blood glucose determination kit was provided by Shanghai Qiaodu Biotechnology Co. Ltd (China). Enzyme-linked immunosorbent assay (ELISA) kits of INS and C-peptide were purchased from Shanghai Lanji Biotechnology Co. Ltd (China). Glycated hemoglobin (HbA1c) determination kit was purchased from Shanghai Huayi Biotechnology Co. Ltd (China). Malondialdehyde (MDA) and superoxide dismutase (SOD) determination kits were obtained from Nanjing Jiancheng Bioengineering Institute (China). Tropicamide was the product of Santen Pharmaceutical Co. Ltd (Japan). Chloral hydrate (7%) was produced by Affiliated Hospital of Taishan Medical University (China). Fluorescein sodium injection was purchased from Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd (China). Fundus camera and slit lamp illumination tester were obtained from Shanghai New Eyes Medical Co. Ltd (China). Eye electrophysiological diagnosis system was obtained from Roland (Germany). Synchronous confocal laser fundus fluorescence angiography was purchased from Heidelberger Druckmaschinen AG (Germany).
Animal
A total of 80 male Sprague Dawley (SD) rats (200 AE 20 g, two months old) were purchased from SPF (Beijing) Experimental Animal Technology Co. Ltd. All rats were housed under controlled conditions (22-24 C, 12:12 h light/dark cycle) and provided with food and water ad libitum. All experiments were approved by the laboratory animals' ethical committee of Taishan Medical University and followed national guidelines for the care and use of animals.
Induction of DM and experimental groups
DM was induced by intravenous injection of STZ (60 mg/ kg) in citrate buffer via tail vein. Only STZ-treated rats with blood glucose levels higher than 13.9 mmol/L at day 3 and day 7 after STZ injection were considered diabetic and were included in the study. In this experiment, 56 out of 64 rats were modeled successfully, and the success rate of model making is 87.5%. The DM rats were randomly allocated into four groups: DM model group (DM), DM with low dosage of PSP group (PSP-L), DM with middle dosage of PSP group (PSP-M) and DM with high dosage of PSP (PSP-H). Every group is composed of 14 DM rats. Another 16 rats were only given sodium citrate in place of STZ and used as blank control group (BC). From the seventh day, BC and DM groups were given normal saline of 1 mL/100 g once a day by gavage. PSP-L, PSP-M and PSP-H groups were given equal amount of PSP saline solution, and the amount of PSP was 200 mg/kg.d, 400 mg/kg.d and 800 mg/kg.d, respectively. This experiment lasted for 12 weeks.
Physical measurements
After modeling, for all rats in each group their food intake, water intake and urine output were measured by metabolic cages every two weeks, and their body weight was measured by electronic balance every one week.
Biochemical analysis
After 12 h overnight fasting, blood samples were collected by angula vein. Fasting blood glucose (FBG) level was measured by glucose-oxidase method using blood glucose meter (One Touch UltraEasy, USA) every one week. HbA1c level was estimated from whole blood collected in EDTA vacutainer by immunoturbidimetry method using automatic biochemical analyzer. Plasma concentrations of INS and C-peptide were determined by ELISA kit according to the manufacturer's instructions. The levels of HbA1c, INS and C-peptide were tested at 0th, 4th, 8th and 12th weeks.
Plasma MDA level was determined by a spectrophotometric measurement of thiobarbituric acid-reactive substances according to the manufacturer's instruction. SOD activity was measured by the Fridovich's method. This method uses xanthine and xanthine oxidase to produce superoxide radicals, which react with p-iodonitrotetrazolium violet to generate a red formazan measured at 505 nm. 10 
Cataract examination
After dilating the pupils of unanesthetized animals with 1% tropicamide, lens opacification was observed by a researcher (blinded to the treatment condition) using slit lamp illumination. To ensure equivalent assessment of cataract for each observation, the slit lamp illumination was standardized to the same slit width and light intensity for all examinations.
Electroretinogram
Rats were anesthetized by intraperitoneal injection of 7% chloral hydrate solution, pupils were dilated with 1% tropicamide, and the corneal surface was anesthetized with 0.5% tetracaine HCl. Full-field electroretinogram (ERG) was performed according to the ISCEV standard. 11 Recordings were made with an electrode placed on the cornea. The reference electrode was placed on ear and the ground electrode was put on posterior fontanelle. Scotopic rod response and oscillatory potentials (OPs) were tested and analyzed eye electrophysiological diagnosis system.
Flash-visual evoked potential
This operation was followed by ERG examination. Before test, anesthetic effect was tested so as to add anesthetic dose, if necessary. Electrode was put on posterior fontanelle, and reference electrode was put at the midpoint of the line between two eyes, and ground electrode was put on the right ear. On the platform of eye electrophysiological diagnosis system, the item of flash-visual evoked potential (F-VEP) was chosen. By fine tuning contact location of every electrode, when the value of resistance was 10 Kohm or less, F-VEPs of two eyes were measured. When the eliciting stimulus was a 1.4 Hz flash, peak times of N1-3 and P1-3 were recorded as well as amplitudes of N1-P1, N2-P2 and N3-P3. Then, the eliciting stimulus was switched to 11 Hz, and peak times of N1 and P1 were recorded as well as amplitude of N1-P1.
Fundus fluorescein angiography
This operation was followed by F-VEP examination. For the rats with cataract, this process was given up. After intraperitoneal injection of fluorescein sodium (10%, 50 mg/kg), the rats were placed on a stereotactic platform, and dynamic fundus photographs were taken.
Statistical analysis
The results are presented as mean AE SD. Statistical analysis was carried out by one-way analysis of variance followed by Student-Newmann-Keuls multiple comparison tests with the SPSS 19.0 software for Windows. P-value less than 0.05 was considered statistically significant.
Results
PSP regulated glucose metabolism and improved clinical symptoms in STZ-induced DM rats
PSP lowered the levels of FBG and HbA1c and elevated the levels of INS and C-peptide in DM rats. Compared with that of BC group, FBG level of DM group was promoted by more than twice after STZ injection (P < 0.001) and continued to elevate throughout the experimental period. While FBG level in DM rats treated with PSP lowered significantly in a dose-dependent manner from first week (Figure 1(a) ). Compared with DM group, middle dosage and high dosage of PSP downregulated FBG level at every experimental time starting from first week (P < 0.01); low dosage of PSP downregulated FBG level as well (P < 0.01 or P < 0.05) during experiment period (except for fifth and sixth weeks).
HbA1c is formed by chemical reaction between hemoglobin and blood glucose. It represents a reliable and moving average of blood glucose over three months. In agreement with FBG level, HbA1c was significantly promoted in DM rats by 73%, 217% and 216% at 4th, 8th and 12th weeks, respectively, compared with BC group; however, PSP interference inhibited the increase of HbA1c level induced by STZ in a dose-dependent manner (Figure 1(b) ). Compared with DM group, HbA1c level of PSP-H group became lower at 4th week (P < 0.05); HbA1c level of PSP-M and PSP-H groups became lower at 8th week (P < 0.01); HbA1c level of PSP-L, PSP-M and PSP-H groups became lower at 12th week (P < 0.01).
As shown in Figure 1 (c), induction of diabetes with STZ resulted in a distinct reduction of INS by 63%, 81%, 83% at 4th, 8th and 12th weeks, respectively, compared with that of BC group. PSP treatment in DM rats led to a higher plasma INS level. Compared with DM group, INS level of PSP-L, PSP-M and PSP-H groups was increased at 4th week (P < 0.01); INS level of PSP-H group was increased at 8th and 12th weeks (P < 0.05).
C-peptide, the product of proinsulin proteolysis, is a chaperone for INS during its storage in transport vesicles of pancreatic b-cells and further is secreted into bloodstream. C-peptide level is reduced in plasma of patients with diabetes mellitus type 1 due to autoimmune destruction of b-cells. 12 In this study, the level of C-peptide was also measured. In agreement with INS level, C-peptide level in plasma of DM group was remarkably decreased by 39%, 49%, 54% at 4th, 8th and 12th weeks, respectively, compared with BC group. PSP promoted C-peptide level of DM rats in a dose-dependent manner (Figure 1(d) ). Compared with DM group, C-peptide level of PSP-L, PSP-M and PSP-H groups was increased at 12th week (P < 0.05 or P < 0.01).
PSP improved clinical symptom of polydipsia, polyphagia, polyuria and weight loss in DM rats. The rats in BC group were very active, swift and well proportioned during the entire experimental period. Their hair was healthy and shiny. With the constant increase of blood glucose, the body of rats in DM group became spindle-like, their hair turned dark yellow and they were in low spirits.
As shown in Tables 1 to 4 , food intake, water intake and urine output of DM rats were greatly increased, whereas their body weight was lost during the experimental period compared with BC group. PSP treatment in DM rats led to a significantly improvement of diabetic typical symptoms induced by STZ injection. The effect of PSP is in a dose-dependent manner.
PSP attenuated oxidative stress in STZ-induced DM rats
Oxidative stress is a serious condition that may result in ocular complications associated with DM. 13 MDA is one of the most reliable and widely used indices of oxidative stress. The toxic effects of reactive oxygen species can be reduced by antioxidants such as SOD. 14 In our study, we determined SOD activity and MDA level in plasma. As shown in Figure 2 , compared with that of BC group, SOD activity in plasma was significantly decreased by 21%, 28%, 29% at 4th, 8th and 12th weeks, respectively, in DM group. Meanwhile MDA level was significantly increased by 95%, 119%, 121% at 4th, 8th and 12th weeks, respectively, in DM group. Compared with that of DM group, PSP significantly promoted SOD activity and lowered MDA level in a dosedependent manner (Figure 2 ).
PSP slowed the progression of ocular complications in STZ-induced DM rats
PSP had anticataract effect on STZ-induced DM rats. The effect of PSP on lens opacity was shown in Figure 3 . During 12-week study period, all lens from BC rats were clear and normal. The eyes in DM group showed lens opacity. In DM group cataract occurred on both left and right eyes of one rat at 6th week, both eyes of two rats at 8th week and both eyes of another two rats during 10-12 weeks. In PSP-L group, cataract was shown on single eye of two rats at 8th week and both eyes of one rat at 10th week. In PSP-M group, cataract was found on both eyes of two rats at 10th week. In PSP-H group, cataract was discovered on single eye of one rat at 12th week.
PSP delayed the procession of DR in STZ-induced DM rats
Effect of PSP on ERG of DM rats. The effect of PSP on ERG was determined and the results were shown in Compared with that of DM group, the amplitude of bwave was significantly elevated at 8th week. As to OPs2, its amplitude under scotopic 3.0 ERG in DM group was lowered by 37% at 12th week compared with that of BC group. At the same time, OPs2 amplitude of PSP-M and PSP-H groups was increased by 31% and 37%, respectively, compared with DM group. There were no differences in peak times of b and OPs2 waves among these five groups at 4th, 8th and 12th weeks. 
Discussion
DM is an important health problem which causes significant morbidity and mortality due to specific microvascular complications (retinopathy, nephropathy and neuropathy) and macrovascular complications (ischemic heart disease and peripheral vasculopathy). The eye is one of the principal organs affected by this disease, and ocular complications associated with DM are progressive rapidly and becoming one of the most important causes of morbidity worldwide. DR is a frequent and serious complication of DM resulting from damage to retinal microvasculature. The retinal cells primarily involved in DR are both endothelial and neuronal cells. The progress of DR is as follows: firstly, when the control of blood glucose is inadequate, DM leads to the weakening of smaller vessel walls, which results in the formation of microaneurysms and then edema, bleeding, and microinfarcts (ischemia). Next, neovascularization occurs which is called ''proliferative stage.'' The new vessels grow in a chaotic way by damaging nervous tissue, causing more serious bleeding and promoting retinal detachment. Therefore, DR is classified into two types: nonproliferative diabetic retinopathy and proliferative diabetic retinopathy. Besides DR, cataract characterized by opacification of crystalline lens is also a complication of DM, 15, 16 which can affect patients at younger age. 17 In general, diabetic cataract attacks in both eyes and develops very swiftly and within several months, weeks or even several days, it will progress to complete opacification of crystalline lens. 18 As an important component of P. siibiricum included in Chinese Pharmacopoeia (ChP), 19 PSP has a variety of medical effects such as anti-inflammation, 20 antioxidation, antiaging, 21 lipid-lowering 22 and blood sugar control. 23 Because PSP has remarkable pharmacological function, cheap price and few side-effects, it has greater potential in application. In our study, the purity of PSP we applied is 98% and it consists of three polysaccharides. The molecular weights of these three polysaccharides are all more than 200 kDa. Polysaccharide I is mainly composed of fructose with b-(1!2) linked backbone, and the glucose is linked to the main chain by a-bond; polysaccharide II is mainly composed of mannose and galactose with 1!6 linkage; polysaccharide III is pectin with partial ethyl esterification. Our results showed that PSP treatment significantly decreased the concentrations of FBG and HbA1c in blood, increased the levels of INS and C-peptide in plasma and lessened the symptom of polydipsia, polyphagia, polyuria and weight loss in STZ-induced DM rats. These data indicate PPS had the effect of regulating glucose metabolism and improving clinical symptoms of DM. More importantly, we discovered for the first time that PSP delayed the progress of cataract and DR and promoted visual function in experimental diabetic rats. These data indicate that PSP has preventive effect on diabetic eye disease.
In our study, we applied ERG and F-VEP to assess retinal and nervous (optic tract) function of rats and used Fundus fluorescein angiography (FFA) technique to observe pathologic change of retinal microvessel. These techniques are safe, repeatable, quick and objective and have been proved to be successful tools for early diagnosis of DR and, potentially, for ophthalmologic follow-up of diabetic patients. ERG is applied to test the operation of the entire surface of neuroretina, only on photoreceptor and outer plexiform layers. The potentials recorded reflect many events are related to different types of cells: photoreceptors, bipolar cells, amacrine cells and Mü ller cells. ERG a-wave response reflects photoreceptor cell function, and b-wave reflects the bioelectrical activities of bipolar and Mü ller cells. 24 The amplitude of ERG b-wave is low in DM without DR patients, and the amplitude is lower in DM with DR patients. 24 However, OP waves are currently considered the most relevant electroretinographic index for DR diagnosis. 25 OP waves might originate from the inhibitory feedback circuits of the inner retinal layers, and they are more sensitive to the changes of blood circulation in retina. The amplitudes of OPs2 and OPs3 have obvious correlation with the severity of DR, i.e. the lower the amplitude is, the more severe DR becomes. 26 In this study, the amplitudes of ERG b and OPs2 waves were decreased in DM group (Figure 4) , which indicated the damage of retinal function and an animal model of DM with DR had been successfully established. PSP treatment reversed the decrease of the two waves, which indicated that PSP had preventive and therapeutic effect on DR by reducing cellular damage and improving retinal blood circulation.
VEPs are defined as changes in bioelectric potentials of occipital cortex evoked by visual stimuli. They are generated by complex neurosensory events related to the translation and transmission of nerve impulses along optic tract from photoreceptors to occipital cortex. They can be elicited with pattern or flash stimuli. The objects of our experiment are rats, and they cannot cooperate well; therefore, F-VEP was applied to carry out the experiment. DM affects both electrophysiological and psychophysical aspects of visual function. A significant reduction in amplitude and increased latency of VEPs were found in DM without signs of retinopathy, 27 which denotes a functional neuronal loss before anatomical abnormalities can be detected. In this study, we also found that the peak time of P2 wave was prolonged, and the amplitude of N2-P2 was lowered in DM group. However, PSP treatment reversed these changes ( Figure 5 ).
In the present study, FFA was performed by injecting intraperitoneally sodium Fuorescein and angiograms obtained showed retinal arterial-venous cycle. Subtle retinal vascular abnormalities, capillary angiography and vascular leakage can be detected only using this procedure. In our study, the retina from DM group showed capillaries' deformation and vascular leakage as evidence on Fuorescein angiograms ( Figure 6 ). Other experimental studies have also revealed similar findings in DR. [28] [29] [30] However, the retina treated by PSP was not detected to have clear vascular leakage, which indicated retinal vasculopathy was weakened. Therefore, it can be referred that PSP treatment has offered a protective effect on diabetes induced vasculopathy from results of present study.
Several different pathogenetic mechanisms precipitate formation of diabetic eye disease. Besides the duration and control of DM, oxidative stress also contributes to the development of DR and cataract. 31, 32 Hyperglycemia causes overproduction of O 2 À , which leads to increased lipid peroxidation level and decreased antioxidase activity, and thereby enhances oxidative stress in subjects with DM. On one hand, oxidative stress can cause the activation of four biochemical pathways, including polyol pathway, advanced glycation end products pathway, protein kinase C pathway and hexosamine pathway. 33 On the other hand, oxidative stress results in an increase in thrombotic tendency and a reduction in prostacyclin-stimulating factors in diabetics. 34 The two aspects contribute to the progress of diabetic eye disease. Our study showed an increased lipid peroxidation in terms of MDA and a decreased antioxidase activity in terms of SOD in DM rats ( Figure 2 ). However, PSP attenuated oxidative stress in the study, which might be one of the mechanisms of preventive effect on ocular complications in DM rats.
In summary, our study revealed that PSP slows the progression of DR and cataract in STZ-induced DM rats. Alleviating hyperglycemia and reducing oxidative stress may be the mechanisms contributing to preventing and delaying the procession of ocular complications associated with DM. This study suggests that PSP is a valuable adjuvant therapy for DM and its ocular complications.
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